Managing public payment for high-cost, high-benefit treatment: enzyme replacement therapy for Gaucher's disease in Ontario.
Clarke
J T
JT
Department of Pediatrics, Hospital for Sick Children, Department of Health Administration, University of Toronto, Toronto, Ont. jtrc@sickkids.on.ca
Amato
D
D
Deber
R B
RB
D003362:Cost-Benefit Analysis; D016527:Drug Costs; D005776:Gaucher Disease / Q000188:drug therapy*; D005962:Glucosylceramidase / Q000191:economics* / Q000627:therapeutic use*; D006291:Health Policy; D006801:Humans; D009864:Ontario; D012051:Reimbursement Mechanisms
D005962:Glucosylceramidase